Compare AGD & AHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AGD | AHG |
|---|---|---|
| Founded | N/A | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Business Services |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 294.6M | 1.2B |
| IPO Year | 2006 | 2017 |
| Metric | AGD | AHG |
|---|---|---|
| Price | $11.90 | $2.25 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 113.6K | 30.9K |
| Earning Date | 01-01-0001 | 08-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.46 | $0.83 |
| 52 Week High | $13.98 | $2.50 |
| Indicator | AGD | AHG |
|---|---|---|
| Relative Strength Index (RSI) | 46.41 | 69.57 |
| Support Level | $11.17 | $1.57 |
| Resistance Level | $12.35 | N/A |
| Average True Range (ATR) | 0.23 | 0.27 |
| MACD | 0.00 | 0.10 |
| Stochastic Oscillator | 51.54 | 89.92 |
Aberdeen Global Dynamic Dividend Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current dividend income, more than 50% of which qualifies for the reduced federal income tax rate, as created by the Jobs and Growth Tax Relief Reconciliation Act of 2003. The fund also focuses on the long-term growth of capital as a secondary investment objective. The fund's portfolio holdings are in information technology, financials, health care, and consumer discretionary sectors, among others.
Akso Health Group is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.